Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Artane

(trihexyphenidyl)

Phase 1Small molecule

WWyeth-Lederle Vaccines

This medication helps manage Parkinson's disease symptoms and side effects from certain other drugs by relaxing muscles and reducing nerve signals that control muscle function.[1] Artane is currently being investigated across 1 indication[3], with its most advanced program in Phase 1.[1]

1

Indications

2

Total Trials

1

Active Trials

0

Competitors

2

FDA Applications

NDA/BLA/ANDA regulatory filings

Pipeline

Status by Indication[3][1]

Indication

Pediatric DisorderRecruiting

Pediatric DisorderPhase 1

Recruiting

Timeline

Expected Milestones

Q4 2029

Phase 1Recruiting

Pediatric Disorder

NCT06554288

Clinical

Trials by Indication[1]

Treatment1 trial

Childhood Hypertonia of Central Origin: A Trial of Anticholinergic Treatment Effects

Completed·UUniversity of Southern California·Phase 2·NCT00122044·35 enrolled

Pediatric Disorder1 trial

Pharmacogenomic Contribution to the Biotransformation of Trihexyphenidyl and Development of a Precision Dosing Model for Children With Dystonia and Cerebral Palsy

Recruiting·CChildren's Mercy Hospital Kansas City·Phase 1·NCT06554288·40 enrolled

Regulatory

FDA Approval Timeline[4]

Jan 1, 1982

ARTANE

NDA NDA006773

Jan 1, 1982

ARTANE

NDA NDA012947

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for trihexyphenidyl. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — trihexyphenidyl compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for trihexyphenidyl. EMBL-EBI & Wellcome Sanger Institute.
[4]
OpenFDA — FDA approval records (NDA NDA006773). U.S. Food & Drug Administration.
[5]
SEC EDGAR — Wyeth-Lederle Vaccines company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: WWyeth-Lederle Vaccines

Related News